Home › Myositis
Pag-aaral pangklinika para sa Myositis na nagre-recruit sa U.S.
20 pag-aaral para sa Myositis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Durham, NC10 pag-aaral
- New York City, NY6 pag-aaral
- Chicago, IL6 pag-aaral
- Boston, MA6 pag-aaral
- Houston, TX5 pag-aaral
- Cedar Rapids, IA4 pag-aaral
- Miami, FL4 pag-aaral
- Washington, DC3 pag-aaral
- Jacksonville, FL3 pag-aaral
- Baltimore, MD3 pag-aaral
- Charlotte, NC3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- Plantation, FL3 pag-aaral
- Los Angeles, CA3 pag-aaral
- Dallas, TX3 pag-aaral
- Orange, CA3 pag-aaral
- Pittsburgh, PA3 pag-aaral
- Gainesville, FL3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- Arizona4 pag-aaral
- California11 pag-aaral
- Florida7 pag-aaral
- Georgia3 pag-aaral
- Illinois7 pag-aaral
- Iowa4 pag-aaral
- Kansas3 pag-aaral
- Maryland6 pag-aaral
- Massachusetts6 pag-aaral
- Michigan3 pag-aaral
- Minnesota4 pag-aaral
- New York7 pag-aaral
- North Carolina12 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee3 pag-aaral
- Texas7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Environmental Risk Factors for the Anti-synthetase Syndrome
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01276470Adult and Juvenile Myositis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00017914RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07103746Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07823101A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104FT839 in Autoimmune Diseases
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06925542Descartes-08 in Autoantibody Myositis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07391605A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07295847A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT07160205Muscle Health Measurements Using Electrical Impedance Myography
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT07502989MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Nagre-recruitObservasyonal na pag-aaral
Edad 7 pataas · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07374107Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Nagre-recruitMaagang Phase 1
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT06479863Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.